Bevacizumab, known by its brand name Avastin, is a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF). VEGF is a signal protein that promotes the growth of new blood vessels. By blocking VEGF, bevacizumab can restrict the blood supply to tumors, thereby inhibiting their growth.
